search
Back to results

A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma

Primary Purpose

B-cell Lymphoma

Status
Terminated
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
Bevacizumab
Rituximab
CHOP
Placebo
Sponsored by
Hoffmann-La Roche
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for B-cell Lymphoma

Eligibility Criteria

18 Years - 79 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adult patients, ≥ 18 and < 80 years of age.
  • CD20-positive diffuse large B-cell lymphoma.
  • Low-intermediate, high-intermediate, or high risk disease and/or bulky tumor (largest diameter ≥ 7.5 cm).
  • Eastern Cooperative Oncology Group (ECOG) performance status 0-2.

Exclusion Criteria:

  • Prior treatment for diffuse large B-cell lymphoma.
  • Types of non-Hodgkin's lymphoma other than diffuse large B-cell lymphoma (DLBCL).
  • Central nervous system (CNS) involvement of lymphoma.

Sites / Locations

  • Uni of California - San Diego; Cancer Center & Dept of Medicine
  • Kenmar Research Inst.
  • University of Colorado Cancer Center Department of Hematology
  • Uni Medical Center; Division Of Hemotology/Oncology
  • Florida Cancer Specialists
  • Northwest Georgia Oncology Centers
  • University of Kansas Medical Center; Department of Hematology
  • St. Joseph Mercy Hospital; Department of Oncology
  • Northeast Oncology Associates
  • Forsyth Regional Cancer Center; Piedmont Hematology/Oncology Associates
  • Providence Portland Medical Center
  • Charleston Cancer Center
  • Uni of Texas Southwestern Medical Center
  • Cancer Therapy & Research Center
  • Northwest Medical Specialties B
  • Rainier Physicians
  • Northwest Medical Specialties
  • Hospital Italiano; Haemathology
  • Fundaleu; Haematology
  • Hospital Britanico; Haematology
  • HOSPITAL PRIVADO - CENTRO MEDICO DE CÓRDOBA; Dpto Oncología
  • Greenslopes Private Hospital; Gallipoli Research Centre
  • Princess Alexandra Hospital Woolloongabba; Clinical Hematology and Medical Oncology
  • Royal Adelaide Hospital; Haematology, Institute of Medical Veterinary Science
  • Ashford Cancer Center Research
  • Frankston Hospital; Oncology/Haematology
  • Peter Maccallum Cancer Institute; Medical Oncology
  • Alfred Hospital; Bone Marrow Transplant Unit
  • Border Medical Oncology; Murray Valley Private Hospital
  • Fremantle Hospital; Haematology
  • Lkh-Univ. Klinikum Graz; Klinik Für Innere Medizin I
  • Lkh Salzburg - Univ. Klinikum Salzburg; Iii. Medizinische Abt.
  • Medizinische Universität Wien; Univ.Klinik für Innere Medizin I - Hämatologie & Hämostaseologie
  • Centro Goiano de Oncologia - CGO
  • Hospital de Caridade de Ijui; Oncologia
  • Hospital das Clinicas - UFRGS; Hematologia
  • Hospital Nossa Senhora da Conceicao
  • Hospital das Clinicas - UNICAMP
  • Faculdade de Medicina do ABC - FMABC; Oncologia e Hematologia
  • Santa Casa de Misericordia de Sao Paulo; Hematologia e Hemoterapia
  • Hospital das Clinicas - FMUSP; Hematologia
  • Tom Baker Cancer Centre; Dept of Medicine
  • Cross Cancer Institute ; Dept of Medical Oncology
  • Cancer Care Manitoba
  • Moncton Hospital
  • Health Science Centre
  • QEII HSC; Oncology
  • Cancer Centre of Southeastern Ontario; Kingston General Hospital
  • Credit Valley Hospital/Carlo Fidani Peel Regional Cancer Centre
  • Toronto Sunnybrook Regional Cancer Centre
  • University Health Network; Princess Margaret Hospital; Medical Oncology Dept
  • Windsor Regional Cancer Centre
  • Hopital Charles Lemoyne; Centre Integre de Lutte Contre Le Cancer de La Monteregie
  • Mcgill University - Royal Victoria Hospital; Oncology
  • McGill University; Sir Mortimer B Davis Jewish General Hospital; Oncology
  • Hopital de L'Enfant-Jesus; Hematology
  • Chuq - Hopital Hotel Dieu de Quebec; Oncology
  • Allan Blair Cancer Centre
  • Saskatoon Cancer Centre; Uni of Saskatoon Campus
  • Cancer Hospital Chinese Academy of Medical Sciences.
  • Beijing Cancer Hospital
  • Beijing Union Hospital
  • General Hospital of Chinese PLA; Department of Hematology
  • Fujian Cancer Hospital
  • Fudan University Shanghai Cancer Center
  • Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
  • Changhai Hospital of Shanghai
  • The Second Affiliated Hospital of Soochow University
  • First Affiliated Hospital of Soochow University
  • Tianjin Institute of Hematology & Blood Diseases Hospital
  • The First Affiliated Hospital of The Fourth Military Medical University (Xijing Hospital)
  • Organizacion Sanitas Internacional
  • Hospital Pablo Tobon Uribe
  • Instituto Cancerologia Medellin; Clinica Las Americas
  • Oncólogos de Occidente
  • Fakultni nemocnice Brno; Interni hematoonkologicka klinika
  • Fn Hr. Kralove; IV. Interni Hematologicka Klinika
  • Fakultni nemocnice Olomouc; Hemato-onkologicka klinika
  • Fakultni Nemocnice Plzen, Hematologicko-Onkologicke Oddeleni
  • VshEOBECNÁ FAKULTNÍ NEMOCNICE; I. INTERNI KLINIKA
  • Fakultní Nemocnice Královské Vinohrady; Hematologická Klinika
  • Teodoro Maldonado Carbo Hospital; Oncology Service
  • Hospital Carlos Andrade Marin; Servicio de Oncología
  • Hospital Solca Quito; Oncologia
  • Clinique Claude Bernard; Onco Hematologie
  • Centre Hospitalier Uni Ire; Service de Medecine D
  • Institut Bergonie; Hematologie Oncologie
  • Polyclinique Bordeaux Nord Aquitaine; Chimiotherapie Radiotherapie
  • Centre Francois Baclesse; Comite 2
  • Chu Estaing; Cons Hemato Medecine Interne
  • Chu Site Du Bocage;Hematologie Clinique
  • CH Dptal Les Oudairies; Hematologie Oncologie
  • Hopital Albert Michallon; Oncologie
  • Clinique Victor Hugo; Chimiotherapie
  • Hopital Claude Huriez; Hematologie
  • Hopital Uni Ire Dupuytren; Hematologie
  • Centre Leon Berard; Departement Oncologie Medicale
  • Institut J Paolii Calmettes; Onco Hematologie 1
  • Clinique Pont de Chaume; Oncologie Et Radiotherapie
  • Hopital Saint Eloi; Hematologie Oncologie Medicale
  • Hopital de L'Archet; Hematologie Clinique
  • Polyclinique Kenval ; Radiotherapie Oncologie
  • Institut Curie; Oncologie Medicale
  • Hopital Saint Louis ; Service d Oncologie Medicale Fougere 6 (Pr Misset)
  • Hopital Pitie Salpetriere; Hematologie Clinique
  • Hopital Saint Jean; Hematologie
  • Hopital De Haut Leveque; Hematologie Clinique
  • Ch Lyon Sud; Hemato Secteur Jules Courmont
  • Hopital De La Miletrie; Hematologie Et Oncologie Medicale
  • Ch Jacques Puel;Oncologie Medicale
  • ICL; Hematologie
  • Hopital Sud; Hematologie Clinique
  • Hopital Purpan; Hematologie Clinique
  • Clinique Pasteur; Oncologie Medicale
  • Hopital Bretonneau; Hematologie Therapie Cellulaire
  • Hopitaux De Brabois; Hematologie Medecine Interne
  • Institut Gustave Roussy; Unite D'Hematologie
  • Gesundheitszentrum St. Marien GmbH; Med. II, Hämatologie/Onkologie
  • Charité-Universitätsm. Berlin; Med. Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunolo.
  • Charité; Onkologie & Hämatologie
  • DIAKO Ev. Diakonie-Krankenhaus Bremen GmbH; Med. Klinik II; Hämatologie und internistische Onkologie
  • Carl-Thiem-Klinik Cottbus; Medizinische Klinik
  • Klinikzentrum Mitte; Medizinische Klinik Gastroenterologie Haematologie / Onkologie
  • St. Johannes Hospital; Abt. Innere Medizin
  • St Antonius Hospital; Haematologie/Onkologie
  • Krankenhaus Nordwest Medizinische Klinik
  • Klinik Fulda; Abt. Itz
  • Universitätsklinikum Greifswald Klinik für Innere Medizin C und Poliklinik
  • Georg-August-Uniklinik ; Zentrum Innere Medizin Abt. Hämatologie & Onkologie
  • Kath.Krankenhaus Hagen gem.GmbH St.-Marien-Hospital
  • Asklepios Klinik St. Georg; Allgemeine Innere Medizin
  • Facharztzentrum Eppendorf, Studien GbR
  • Evang.Krankenhaus Abt. Hämatologie und Onkologie
  • St.-Marien-Hospital Klinik Knappenstraße; Klinik für Hämatologie und Onkologie
  • KRH Klinikum Siloah Medizinische Klinik III
  • St. Bernward-Krankenhaus
  • Universitaetsklinikum des Saarlandes; medizinische Klinik und Poliklinik; Innere Medizin I
  • Städtisches Klinikum Karlsruhe gGmbH, II. Medizinische Klinik
  • St. Vincentius Kliniken Ag; Medizinische Klinik Abt. 2
  • Tagesklinik Landshut; Hämatologie/Onkologie
  • Universitätsklinikum Leipzig Medizinische Klinik II Gastroenterolog. u. Hepatolog.
  • Klinikum St.Georg gGmbH Klinik für Internistische Onkologie und Hämotologie
  • Klinikum der Stadt Ludwigshafen; Medizinische Klinik A
  • Universitätsklinikum Schleswig-Holstein / Campus Lübeck, Med. Klinik I, Hämatologie/Onkologie
  • Märkische Kliniken GmbH, Klinikum Lüdenscheid; Hämatologie / Onkologie
  • Otto von Guericke Uni Magdeburg Uniklinik; Hämatologie/Onkologie
  • Klinikum Magdeburg gemeinnützige GmbH; Klinik Haematologie und Onkologie
  • Klinikum Mannheim III. Medizinische Klinik
  • Klinikum der Universitaet Muenchen; Campus Großhadern; Medizinische Klinik III und Poliklinik
  • Westfälische Wilhelms-Universität Münster, Medizinische Klinik und Poliklinik A
  • Klinikum Oldenburg gGmbH; Klinik für Onkologie und Hämatologie
  • Prosper-Hospital, Medizinische Klinik I
  • St Marien Krankenhaus; Medizinische Klinik Iii
  • Klinikum Mutterhaus der Borromaeerinnen gGmbH; Haematologie/Onkologie
  • Krankenhaus der Barmherzigen Brüder Trier; Innere Medizin I, Hämatologie / Internistische Onkologie
  • Eberhard-Karls-Universität Tübingen; Medizinische Klinik I
  • Universitätsklinikum Ulm; Medizinische Uni-Klinik III Abt. Innere Medizin III Hämatologie u. Onkolo.
  • HSK Dr.-Horst-Schmidt-Kliniken; Innere Medizin I Kardiologie; Angiologie und Intensivmedizin
  • Helios Klinik Wuppertal; Medizinische Klinik I
  • Kliniken St. Antonius; Zentrum Für Innere Medizin, Haematologie/Onkologie
  • Georgios Papanikolaou Hospital; Hematology Department
  • Queen Elizabeth Hospital; Clinical Oncology
  • Queen Mary Hospital; Dept of Medicine
  • Fov. Onk. Egyesitett Szent Istvan es Szent Laszlo Korhaz; Dept Of Bone Marrow Transplant
  • National Institute of Oncology, A Dept of Internal Medicine
  • University of Debrecen Medical and Health Science Center, Institute of Internal Medicine, Hematology
  • A.O. Universitaria Policlinico S.Orsola-Malpighi Di Bologna
  • Ospedale Regionale Di Parma; Divisione Di Oncologia Medica
  • Az. Osp. Arcispedale S. Maria Nuova; U.O. Di Ematologia
  • Irccs Centro Di Riferimento Oncologico (CRO); Dipartimento Di Oncologia Medica
  • A.O. Universitaria S. Maria Della Misericordia Di Udine; Oncologia; Clinica Ematologica
  • Univ. Cattolica La Sapienza; Cattedra Di Ematologia
  • ASST DI MONZA; Ematologia
  • Irccs Policlinico San Matteo; Divisione Di Ematologia
  • Ospedale Gen.Le Prov.Le 'C.G.Mazzoni'; Ematologia
  • Università Cattolica Del Sacro Cuore S.S. Giovanni Paolo Ii; Uoc Di Onco-Ematologia
  • Az. Osp. S. Luigi Gonzaga; Malattie Apparato Respiratorio 5 Ad Indirizzo Oncologico
  • A.O. Universitaria S. Giovanni Battista-Molinette Di Torino; Ematologia 1
  • Irccs Ist. Tumori Giovanni Paolo Ii; Dipartimento Oncologia Medica
  • Ospedale Ferrarotto; Divisione Di Ematologia
  • Ospedale Santa Chiara; Unita Operativa Di Ematologia
  • Samsung Medical Centre; Oncology
  • Asan Medical Center, Uni Ulsan Collegemedicine; Dept.Internal Medicine / Divisionhematology/Oncology
  • Korean Cancer Center Hospital; Oncology
  • Severance Hospital - Yonsei University; Medicine Dept.
  • Seamen' Hospital' Dept. of haematology
  • Uni Hospital Santariskiu Clinic; Haematology
  • Hospital Pulau Pinang
  • Instituto Biomedico De Investigacion A.C.
  • Hospital Español; Hematología Sala 19
  • Col Instituto Tecnologico Y Estudios Superiores de Monterrey
  • Hospital Universitario Dr. Jose E. Gonzalez; Haematology
  • North Shore Hospital; Haematolgy
  • Uni of Auckland; Dept of Molecular Medicine & Haematology
  • Christchurch Hospital; Canterbury Health Laboratories
  • Centro Hemato Oncologico Paitilla
  • Hospital Nacional Almanzor Aguinaga Asenjo; Unidad De Investigacion Del Servicio De Oncologia Medica
  • Hospital Nacional Edgardo Rebagliati Martins; Oncologia
  • Hospital Nacional Guillermo Almenara Irigoyen; Oncology
  • Instituto Nacional de Enfermedades Neoplasicas
  • Hospital Nacional LNS dela Policia Nacional del Perú. Unidad Onco; Deapartamento de Oncología
  • Cebu Cancer Institute; Perpetual Succour Hospital
  • National Kidney and Transplant Institute; Chemotherapy Unit
  • St Luke'S Medical Centre; Oncology
  • Szpital Specjalistyczny Podkarpacki Ośrodek Onkologiczny
  • Szpital Uniwersytecki W Krakowie; Klinika Hematologii
  • Medical University School; Dept. of Haematology
  • Katedra i Klinika Hematoonkologii i Transplantacji Szpiku; Uniwersytetu Medycznego w Lublinie
  • Zaklad Opieki Zdrowotnej Mswia; Oddzial Chemioterapii
  • Samodzielny Publiczny Centralny Szpital Kliniczny; Haematology Dept.
  • Centralny Szpital Kliniczny Mswia; Klinika onkologii, hematologii i chorob wewnetrznych
  • Centrum Onkologii - Inst.Im. Marii Sklodowskiej-Curie; Lymphoma Dept.
  • HUC; Servico de Hematologia
  • IPO de Lisboa; Servico de Hematologia
  • Hospital de Sao Joao; Servico de Hematologia Clinica
  • Republican Clinical Oncologic Dispensary of Republic Of Tatarstan
  • N.N.Blokhin Russian Cancer Research Center; Dept. of Chemotherapy & Hemoblastosis
  • Haematology Research Center; Haematology
  • Semashko Central Clinical Hospital Moscow; Hematology
  • Research Inst. of Hematology & Blood Transfusion ; Hematology
  • National Cancer Inst. ; Dept. of Chemotherapy
  • Hospital Mutua de Terrassa; Servicio de Hematologia
  • Hospital Universitario Marques de Valdecilla; Servicio de Hematologia
  • Complejo Hospitalario Universitario A Coruña (CHUAC); Servicio de Hematologia
  • Hospital Universitario de Canarias;servicio de Oncologia
  • Hospital de Basurto; Servicio de Hematologia
  • Hospital de Galdakano
  • Hospital de la Santa Creu i Sant Pau; Servicio de Hematologia
  • Hospital Universitari Vall d'Hebron; Servicio de Hematologia
  • Hospital Clínic i Provincial; Servicio de Hematología y Oncología
  • Hospital Duran i Reynals; Servicio de Hematologia
  • Complejo Hospitalario de Jaen- Hospital Universitario Medico Quirurgico; Servicio de Hematologia
  • Hospital Universitario Clínico San Carlos; Servicio de Hematología
  • Hospital Universitario la Paz; Servicio de Hematologia
  • Hospital Clinico Universitario Virgen de la Victoria; Servicio de Oncologia
  • Hospital Clinico Universitario de Salamanca;Servicio de Hematologia
  • Hospital Universitario Virgen del Rocio; Servicio de Hematologia
  • Hospital Universitario la Fe; Servicio de Medicina Intena
  • Hospital Clinico Universitario de Valencia; Servicio de Onco-hematologia
  • Hospital Universitario Miguel Servet; Servicio Hematologia
  • Skånes University Hospital, Skånes Department of Onclology
  • Skånes Universitetssjukhus; Kliniska Forskningsenheten Onkologimottagning medicinsk behandling
  • Länssjukhuset; Medicinkliniken
  • Akademiska sjukhuset, Onkologkliniken
  • Universitätsspital Zürich; Klinik für Onkologie
  • Veterans General Hospital; Division of Oncology
  • Koo Foundation Sun Yat-Sen Cancer Center; Hemato-Oncology
  • Chang Gung Medical Foundation-Taipei
  • King Chulalongkorn Memorial Hospital; Division of Hematology, Department of Medicine
  • National Cancer Inst.
  • Rajavithi Hospital; Medicine
  • Siriraj Hospital; Division of Hematology, Department of Medicine
  • Chiang Mai Uni Hospital; Division of Hematology,Dept of Medicine,Faculty of Medicine
  • Srinagarind Hospital, Khon Kaen Uni ; Dept of Medicine
  • Birmingham Heartlands Hospital; Department of Haematology
  • Bradford Royal Infirmary; Haematology Department
  • North Hampshire Hospital; Dept. of Haematology
  • Princess Alexandra Hospital; Department of Haematology
  • Leicester Royal Infirmary; Dept. of Medical Oncology
  • Royal Liverpool Uni Hospital; Haematology
  • St. George'S Hospital; Haematology
  • Hillingdon Hospital
  • Churchill Hospital; Oxford Cancer and Haematology Centre
  • Royal Hallamshire Hospital; Haematology Dept
  • Weston Park Hospital; Cancer Clinical Trials Centre
  • The Royal Wolverhampton Hospitals NHS Trust; Department of Haematology

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Bevacizumab + rituximab + CHOP

Placebo + rituximab + CHOP

Arm Description

Patients received bevacizumab 5 mg/kg/week on Day 1 of each cycle + rituximab 375 mg/m^2 intravenously (IV) on Day 1 of each cycle + CHOP (cyclophosphamide, hydroxydaunorubicin [doxorubicin], Oncovin [vincristine], prednisone).

Patients received placebo to bevacizumab on Day 1 of each cycle + rituximab 375 mg/m^2 intravenously (IV) on Day 1 of each cycle + CHOP (cyclophosphamide, hydroxydaunorubicin [doxorubicin], Oncovin [vincristine], prednisone).

Outcomes

Primary Outcome Measures

Progression-free Survival (PFS)
PFS was defined as the time from the date of randomization to the date of disease progression (PD)/relapse, as determined by the investigator, or death from any cause, whichever occurred earlier. A patient with PD/relapse must meet at least 1 of the following criteria: (1) Appearance of any new lesion > 1.0 cm in the short axis during or at the end of therapy. (2) ≥ 50 % increase from nadir in the sum of the products of diameters (SPD, maximum diameter of a tumor x largest diameter perpendicular to the maximum diameter) of any previously involved nodes, in a single involved node, or the size of other lesions (eg, splenic or hepatic nodules). To be considered progressive disease, a lymph node with a diameter of the short axis < 1.0 cm must increase by ≥ 50% to a size of 1.5 x 1.5 cm or > 1.5 cm in the long axis. (3) ≥ 50 % increase in the greatest diameter of any previously identified node > 1.0 cm in its short axis or in the SPD of more than 1 node.

Secondary Outcome Measures

Overall Survival
Overall survival was defined as the time from the date of randomization to the date of death due to any cause.
Overall Response (OR) Assessed According to the Revised Response Criteria for Malignant Lymphoma
OR = a complete response (CR), an unconfirmed CR, or a partial response (PR). CR = Complete disappearance of disease and disease-related symptoms. All lymph nodes and nodal masses regressed on computed tomography (CT) to normal size (≤ 1.5 cm in their greatest transverse diameter for nodes > 1.5 cm prior to therapy and ≤ 1.0 cm in their short axis for nodes 1.1-1.5 cm in their long axis and > 1.0 cm in their short axis prior to therapy). Spleen and/or liver not palpable on physical examination, normal size by imaging, and disappearance of nodules related to lymphoma. If bone marrow was involved prior to therapy, infiltrate must have cleared on repeat biopsy. PR = ≥ 50% decrease in sum of the product of the diameters (SPD) of up to 6 of the largest dominant nodes or nodal masses. No increase in the size of the other nodes, liver, or spleen. Splenic and hepatic nodules regressed by ≥ 50% in their SPD or, for single nodules, in the greatest transverse diameter. No new sites of disease.

Full Information

First Posted
June 14, 2007
Last Updated
June 26, 2017
Sponsor
Hoffmann-La Roche
Collaborators
Genentech, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT00486759
Brief Title
A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma
Official Title
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Trial Comparing the Efficacy of Bevacizumab in Combination With Rituximab and CHOP (R-CHOP + Bevacizumab) Versus Rituximab and CHOP (R-CHOP) in Previously Untreated Patients With CD20-positive Diffuse Large B-cell Lymphoma (DLBCL)
Study Type
Interventional

2. Study Status

Record Verification Date
June 2017
Overall Recruitment Status
Terminated
Why Stopped
Due to an unfavorable benefit/risk ratio.
Study Start Date
July 26, 2007 (Actual)
Primary Completion Date
November 30, 2011 (Actual)
Study Completion Date
November 30, 2011 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hoffmann-La Roche
Collaborators
Genentech, Inc.

4. Oversight

5. Study Description

Brief Summary
This 2-arm study was designed to compare the efficacy and safety of bevacizumab (Avastin) in combination with rituximab (MabThera) and CHOP (cyclophosphamide, hydroxydaunorubicin [doxorubicin], Oncovin [vincristine], prednisone) chemotherapy (R-CHOP) versus rituximab plus CHOP chemotherapy (R-CHOP) in previously untreated patients with CD20-positive diffuse large B-cell lymphoma (DLBCL). Patients were randomized to receive 8 cycles of treatment with R-CHOP plus bevacizumab or R-CHOP plus placebo. Treatment with bevacizumab/placebo and R-CHOP was given either on a 2-week or 3-week schedule and bevacizumab was given at a weekly average dose of 5 mg/kg (10 mg/kg for 2-week cycles and 15 mg/kg for 3-week cycles).
Detailed Description
An independent Data and Safety Monitoring Board (DSMB) was established to review safety data collected during the study on an ongoing basis. At its meeting in December 2009, the DSMB noted a trend for increased cardiac toxicity in the experimental arm (R-CHOP + bevacizumab) compared with the control arm (R-CHOP + placebo). Additional efficacy analyses of data from 720 randomized patients were presented at a DSMB meeting on May 22, 2010; they indicated no improvement in efficacy with the addition of bevacizumab to R-CHOP. It was noted, however, that there was an apparent increase in the risk of cardiotoxicity, premature treatment withdrawal, serious adverse events (SAEs), fatal adverse events (AEs), and perforation/ulcer in the experimental arm. Based on its assessment of an increased risk with unlikely benefit for patients randomized to the experimental arm, the DSMB recommended that further enrollment in the study be permanently halted and that bevacizumab be discontinued for any patients randomized to the experimental arm. On May 31, 2010, the sponsor took the decision to stop enrollment into the study and the bevacizumab treatment was terminated with immediate effect as recommended by the DSMB. The study protocol was amended. The primary objective of the study was changed from evaluation of efficacy to evaluation of safety and the study was extended to include an 18-month safety follow-up period. Because enrollment was terminated prematurely resulting in fewer enrolled patients than planned, the outcome measure data are premature due to fewer than expected events. The time frame for the reporting of serious adverse events was modified. Serious adverse events (SAE) unrelated to study treatment were reported until 1 year post-treatment or until new anti-lymphoma treatment was initiated. SAEs judged to be related to study treatment and congestive heart failure events were reported at any time during the study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
B-cell Lymphoma

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
787 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Bevacizumab + rituximab + CHOP
Arm Type
Experimental
Arm Description
Patients received bevacizumab 5 mg/kg/week on Day 1 of each cycle + rituximab 375 mg/m^2 intravenously (IV) on Day 1 of each cycle + CHOP (cyclophosphamide, hydroxydaunorubicin [doxorubicin], Oncovin [vincristine], prednisone).
Arm Title
Placebo + rituximab + CHOP
Arm Type
Active Comparator
Arm Description
Patients received placebo to bevacizumab on Day 1 of each cycle + rituximab 375 mg/m^2 intravenously (IV) on Day 1 of each cycle + CHOP (cyclophosphamide, hydroxydaunorubicin [doxorubicin], Oncovin [vincristine], prednisone).
Intervention Type
Drug
Intervention Name(s)
Bevacizumab
Other Intervention Name(s)
Avastin
Intervention Description
Bevacizumab was administered at a dose of 15 mg/kg IV on Day 1 of each 21-day cycle for 8 cycles or at a dose 10 mg/kg IV on Day 1 of each 14-day cycle for 8 cycles. The cycle duration (14- or 21-day) was chosen by each center prior to initiation of the study and was the same for all patients enrolled at that center.
Intervention Type
Drug
Intervention Name(s)
Rituximab
Other Intervention Name(s)
MabThera
Intervention Description
Rituximab was administered at a dose of 375 mg/m^2 IV on Day 1 of each 14- or 21-day cycle for 8 cycles. The cycle duration (14- or 21-day) was chosen by each center prior to initiation of the study and was the same for all patients enrolled at that center.
Intervention Type
Drug
Intervention Name(s)
CHOP
Intervention Description
Cyclophosphamide was administered at a dose of 750 mg/m^2 IV on Day 1 of each cycle. Doxorubicin was administered at a dose of 50 mg/m^2 IV on Day 1 of each cycle. Vincristine was administered at a dose of 1.4 mg/m^2 IV (maximum of 2 mg) on Day 1 of each cycle. Prednisone was administered at a dose of 100 mg orally on Days 1-5 of each cycle. All 4 drugs were administered either every 21 days for 8 cycles or every 14 days for 6 cycles. The cycle duration (14- or 21-day) was chosen by each center prior to initiation of the study and was the same for all patients enrolled at that center.
Intervention Type
Drug
Intervention Name(s)
Placebo
Intervention Description
Placebo to bevacizumab was administered on Day 1 of each 14- or 21-day cycle for 8 cycles. The cycle duration (14- or 21-day) was chosen by each center prior to initiation of the study and was the same for all patients enrolled at that center.
Primary Outcome Measure Information:
Title
Progression-free Survival (PFS)
Description
PFS was defined as the time from the date of randomization to the date of disease progression (PD)/relapse, as determined by the investigator, or death from any cause, whichever occurred earlier. A patient with PD/relapse must meet at least 1 of the following criteria: (1) Appearance of any new lesion > 1.0 cm in the short axis during or at the end of therapy. (2) ≥ 50 % increase from nadir in the sum of the products of diameters (SPD, maximum diameter of a tumor x largest diameter perpendicular to the maximum diameter) of any previously involved nodes, in a single involved node, or the size of other lesions (eg, splenic or hepatic nodules). To be considered progressive disease, a lymph node with a diameter of the short axis < 1.0 cm must increase by ≥ 50% to a size of 1.5 x 1.5 cm or > 1.5 cm in the long axis. (3) ≥ 50 % increase in the greatest diameter of any previously identified node > 1.0 cm in its short axis or in the SPD of more than 1 node.
Time Frame
Baseline to end of the study (up to 4 years, 4 months)
Secondary Outcome Measure Information:
Title
Overall Survival
Description
Overall survival was defined as the time from the date of randomization to the date of death due to any cause.
Time Frame
Baseline to end of the study (up to 4 years, 4 months)
Title
Overall Response (OR) Assessed According to the Revised Response Criteria for Malignant Lymphoma
Description
OR = a complete response (CR), an unconfirmed CR, or a partial response (PR). CR = Complete disappearance of disease and disease-related symptoms. All lymph nodes and nodal masses regressed on computed tomography (CT) to normal size (≤ 1.5 cm in their greatest transverse diameter for nodes > 1.5 cm prior to therapy and ≤ 1.0 cm in their short axis for nodes 1.1-1.5 cm in their long axis and > 1.0 cm in their short axis prior to therapy). Spleen and/or liver not palpable on physical examination, normal size by imaging, and disappearance of nodules related to lymphoma. If bone marrow was involved prior to therapy, infiltrate must have cleared on repeat biopsy. PR = ≥ 50% decrease in sum of the product of the diameters (SPD) of up to 6 of the largest dominant nodes or nodal masses. No increase in the size of the other nodes, liver, or spleen. Splenic and hepatic nodules regressed by ≥ 50% in their SPD or, for single nodules, in the greatest transverse diameter. No new sites of disease.
Time Frame
At the end of treatment (Cycle 8, up to 12 months)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
79 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult patients, ≥ 18 and < 80 years of age. CD20-positive diffuse large B-cell lymphoma. Low-intermediate, high-intermediate, or high risk disease and/or bulky tumor (largest diameter ≥ 7.5 cm). Eastern Cooperative Oncology Group (ECOG) performance status 0-2. Exclusion Criteria: Prior treatment for diffuse large B-cell lymphoma. Types of non-Hodgkin's lymphoma other than diffuse large B-cell lymphoma (DLBCL). Central nervous system (CNS) involvement of lymphoma.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Clinical Trials
Organizational Affiliation
Hoffmann-La Roche
Official's Role
Study Director
Facility Information:
Facility Name
Uni of California - San Diego; Cancer Center & Dept of Medicine
City
La Jolla
State/Province
California
ZIP/Postal Code
92093
Country
United States
Facility Name
Kenmar Research Inst.
City
Whittier
State/Province
California
ZIP/Postal Code
90603
Country
United States
Facility Name
University of Colorado Cancer Center Department of Hematology
City
Aurora
State/Province
Colorado
ZIP/Postal Code
80045
Country
United States
Facility Name
Uni Medical Center; Division Of Hemotology/Oncology
City
Jacksonville
State/Province
Florida
ZIP/Postal Code
32207
Country
United States
Facility Name
Florida Cancer Specialists
City
West Palm Beach
State/Province
Florida
ZIP/Postal Code
33401
Country
United States
Facility Name
Northwest Georgia Oncology Centers
City
Marietta
State/Province
Georgia
ZIP/Postal Code
30060
Country
United States
Facility Name
University of Kansas Medical Center; Department of Hematology
City
Kansas City
State/Province
Kansas
ZIP/Postal Code
66160
Country
United States
Facility Name
St. Joseph Mercy Hospital; Department of Oncology
City
Ann Arbor
State/Province
Michigan
ZIP/Postal Code
48106
Country
United States
Facility Name
Northeast Oncology Associates
City
Concord
State/Province
North Carolina
ZIP/Postal Code
28025
Country
United States
Facility Name
Forsyth Regional Cancer Center; Piedmont Hematology/Oncology Associates
City
Winston-Salem
State/Province
North Carolina
ZIP/Postal Code
27103
Country
United States
Facility Name
Providence Portland Medical Center
City
Portland
State/Province
Oregon
ZIP/Postal Code
97213
Country
United States
Facility Name
Charleston Cancer Center
City
Charleston
State/Province
South Carolina
ZIP/Postal Code
29406
Country
United States
Facility Name
Uni of Texas Southwestern Medical Center
City
Dallas
State/Province
Texas
ZIP/Postal Code
75390-9063
Country
United States
Facility Name
Cancer Therapy & Research Center
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78229
Country
United States
Facility Name
Northwest Medical Specialties B
City
Federal Way
State/Province
Washington
ZIP/Postal Code
98003
Country
United States
Facility Name
Rainier Physicians
City
Puyallup
State/Province
Washington
ZIP/Postal Code
98372
Country
United States
Facility Name
Northwest Medical Specialties
City
Tacoma
State/Province
Washington
ZIP/Postal Code
98405
Country
United States
Facility Name
Hospital Italiano; Haemathology
City
Buenos Aires
ZIP/Postal Code
1425
Country
Argentina
Facility Name
Fundaleu; Haematology
City
Buenos Aires
ZIP/Postal Code
C1114AAN
Country
Argentina
Facility Name
Hospital Britanico; Haematology
City
Buenos Aires
ZIP/Postal Code
C1280AEB
Country
Argentina
Facility Name
HOSPITAL PRIVADO - CENTRO MEDICO DE CÓRDOBA; Dpto Oncología
City
Córdoba
ZIP/Postal Code
5016
Country
Argentina
Facility Name
Greenslopes Private Hospital; Gallipoli Research Centre
City
Greenslopes
State/Province
Queensland
ZIP/Postal Code
4120
Country
Australia
Facility Name
Princess Alexandra Hospital Woolloongabba; Clinical Hematology and Medical Oncology
City
Woolloongabba
State/Province
Queensland
ZIP/Postal Code
4102
Country
Australia
Facility Name
Royal Adelaide Hospital; Haematology, Institute of Medical Veterinary Science
City
Adelaide
State/Province
South Australia
ZIP/Postal Code
5000
Country
Australia
Facility Name
Ashford Cancer Center Research
City
Kurralta Park
State/Province
South Australia
ZIP/Postal Code
5037
Country
Australia
Facility Name
Frankston Hospital; Oncology/Haematology
City
Frankston
State/Province
Victoria
ZIP/Postal Code
3199
Country
Australia
Facility Name
Peter Maccallum Cancer Institute; Medical Oncology
City
Melbourne
State/Province
Victoria
ZIP/Postal Code
3000
Country
Australia
Facility Name
Alfred Hospital; Bone Marrow Transplant Unit
City
Melbourne
State/Province
Victoria
ZIP/Postal Code
3181
Country
Australia
Facility Name
Border Medical Oncology; Murray Valley Private Hospital
City
Wodonga
State/Province
Victoria
ZIP/Postal Code
3690
Country
Australia
Facility Name
Fremantle Hospital; Haematology
City
Fremantle
State/Province
Western Australia
ZIP/Postal Code
6160
Country
Australia
Facility Name
Lkh-Univ. Klinikum Graz; Klinik Für Innere Medizin I
City
Graz
ZIP/Postal Code
8036
Country
Austria
Facility Name
Lkh Salzburg - Univ. Klinikum Salzburg; Iii. Medizinische Abt.
City
Salzburg
ZIP/Postal Code
5020
Country
Austria
Facility Name
Medizinische Universität Wien; Univ.Klinik für Innere Medizin I - Hämatologie & Hämostaseologie
City
Wien
ZIP/Postal Code
1090
Country
Austria
Facility Name
Centro Goiano de Oncologia - CGO
City
Goiania
State/Province
GO
ZIP/Postal Code
74140-050
Country
Brazil
Facility Name
Hospital de Caridade de Ijui; Oncologia
City
Ijui
State/Province
RS
ZIP/Postal Code
98700-000
Country
Brazil
Facility Name
Hospital das Clinicas - UFRGS; Hematologia
City
Porto Alegre
State/Province
RS
ZIP/Postal Code
90035-903
Country
Brazil
Facility Name
Hospital Nossa Senhora da Conceicao
City
Porto Alegre
State/Province
RS
ZIP/Postal Code
91350-200
Country
Brazil
Facility Name
Hospital das Clinicas - UNICAMP
City
Campinas
State/Province
SP
ZIP/Postal Code
13083-888
Country
Brazil
Facility Name
Faculdade de Medicina do ABC - FMABC; Oncologia e Hematologia
City
Santo Andre
State/Province
SP
ZIP/Postal Code
09060-650
Country
Brazil
Facility Name
Santa Casa de Misericordia de Sao Paulo; Hematologia e Hemoterapia
City
Sao Paulo
State/Province
SP
ZIP/Postal Code
01221-020
Country
Brazil
Facility Name
Hospital das Clinicas - FMUSP; Hematologia
City
Sao Paulo
State/Province
SP
ZIP/Postal Code
05403-000
Country
Brazil
Facility Name
Tom Baker Cancer Centre; Dept of Medicine
City
Calgary
State/Province
Alberta
ZIP/Postal Code
T2N 4N2
Country
Canada
Facility Name
Cross Cancer Institute ; Dept of Medical Oncology
City
Edmonton
State/Province
Alberta
ZIP/Postal Code
T6G 1Z2
Country
Canada
Facility Name
Cancer Care Manitoba
City
Winnipeg
State/Province
Manitoba
ZIP/Postal Code
R3E 0V9
Country
Canada
Facility Name
Moncton Hospital
City
Moncton
State/Province
New Brunswick
ZIP/Postal Code
E1C 6Z8
Country
Canada
Facility Name
Health Science Centre
City
St. John's
State/Province
Newfoundland and Labrador
ZIP/Postal Code
A1B 3V6
Country
Canada
Facility Name
QEII HSC; Oncology
City
Halifax
State/Province
Nova Scotia
ZIP/Postal Code
B3H 2Y9
Country
Canada
Facility Name
Cancer Centre of Southeastern Ontario; Kingston General Hospital
City
Kingston
State/Province
Ontario
ZIP/Postal Code
K7L 5P9
Country
Canada
Facility Name
Credit Valley Hospital/Carlo Fidani Peel Regional Cancer Centre
City
Mississauga
State/Province
Ontario
ZIP/Postal Code
L5M 2N1
Country
Canada
Facility Name
Toronto Sunnybrook Regional Cancer Centre
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M4N 3M5
Country
Canada
Facility Name
University Health Network; Princess Margaret Hospital; Medical Oncology Dept
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5G 2M9
Country
Canada
Facility Name
Windsor Regional Cancer Centre
City
Windsor
State/Province
Ontario
ZIP/Postal Code
N8W 2X3
Country
Canada
Facility Name
Hopital Charles Lemoyne; Centre Integre de Lutte Contre Le Cancer de La Monteregie
City
Greenfield Park
State/Province
Quebec
ZIP/Postal Code
J4V 2H1
Country
Canada
Facility Name
Mcgill University - Royal Victoria Hospital; Oncology
City
Montreal
State/Province
Quebec
ZIP/Postal Code
H3A 1A1
Country
Canada
Facility Name
McGill University; Sir Mortimer B Davis Jewish General Hospital; Oncology
City
Montreal
State/Province
Quebec
ZIP/Postal Code
H3T 1E2
Country
Canada
Facility Name
Hopital de L'Enfant-Jesus; Hematology
City
Quebec City
State/Province
Quebec
ZIP/Postal Code
G1J 1Z4
Country
Canada
Facility Name
Chuq - Hopital Hotel Dieu de Quebec; Oncology
City
Quebec City
State/Province
Quebec
ZIP/Postal Code
G1R 2J6
Country
Canada
Facility Name
Allan Blair Cancer Centre
City
Regina
State/Province
Saskatchewan
ZIP/Postal Code
S4T 7T1
Country
Canada
Facility Name
Saskatoon Cancer Centre; Uni of Saskatoon Campus
City
Saskatoon
State/Province
Saskatchewan
ZIP/Postal Code
S7N 4H4
Country
Canada
Facility Name
Cancer Hospital Chinese Academy of Medical Sciences.
City
Beijing
ZIP/Postal Code
100021
Country
China
Facility Name
Beijing Cancer Hospital
City
Beijing
ZIP/Postal Code
100142
Country
China
Facility Name
Beijing Union Hospital
City
Beijing
ZIP/Postal Code
100730
Country
China
Facility Name
General Hospital of Chinese PLA; Department of Hematology
City
Beijing
ZIP/Postal Code
100853
Country
China
Facility Name
Fujian Cancer Hospital
City
Fuzhou
ZIP/Postal Code
350014
Country
China
Facility Name
Fudan University Shanghai Cancer Center
City
Shanghai
ZIP/Postal Code
200032
Country
China
Facility Name
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
City
Shanghai
ZIP/Postal Code
200127
Country
China
Facility Name
Changhai Hospital of Shanghai
City
Shanghai
ZIP/Postal Code
200433
Country
China
Facility Name
The Second Affiliated Hospital of Soochow University
City
Suzhou
ZIP/Postal Code
215004
Country
China
Facility Name
First Affiliated Hospital of Soochow University
City
Suzhou
ZIP/Postal Code
215006
Country
China
Facility Name
Tianjin Institute of Hematology & Blood Diseases Hospital
City
Tianjin
ZIP/Postal Code
300020
Country
China
Facility Name
The First Affiliated Hospital of The Fourth Military Medical University (Xijing Hospital)
City
Xi'an
ZIP/Postal Code
710032
Country
China
Facility Name
Organizacion Sanitas Internacional
City
Bogota
Country
Colombia
Facility Name
Hospital Pablo Tobon Uribe
City
Medellin-Antioquia
Country
Colombia
Facility Name
Instituto Cancerologia Medellin; Clinica Las Americas
City
Medellin
ZIP/Postal Code
2A-80
Country
Colombia
Facility Name
Oncólogos de Occidente
City
Pereira
ZIP/Postal Code
600004
Country
Colombia
Facility Name
Fakultni nemocnice Brno; Interni hematoonkologicka klinika
City
Brno
ZIP/Postal Code
625 00
Country
Czechia
Facility Name
Fn Hr. Kralove; IV. Interni Hematologicka Klinika
City
Hradec Kralove
ZIP/Postal Code
500 05
Country
Czechia
Facility Name
Fakultni nemocnice Olomouc; Hemato-onkologicka klinika
City
Olomouc
ZIP/Postal Code
775 20
Country
Czechia
Facility Name
Fakultni Nemocnice Plzen, Hematologicko-Onkologicke Oddeleni
City
Plzen - Lochotin
ZIP/Postal Code
304 60
Country
Czechia
Facility Name
VshEOBECNÁ FAKULTNÍ NEMOCNICE; I. INTERNI KLINIKA
City
Praha 2
ZIP/Postal Code
128 08
Country
Czechia
Facility Name
Fakultní Nemocnice Královské Vinohrady; Hematologická Klinika
City
Praha
ZIP/Postal Code
100 34
Country
Czechia
Facility Name
Teodoro Maldonado Carbo Hospital; Oncology Service
City
Guayaquil
ZIP/Postal Code
EC090150
Country
Ecuador
Facility Name
Hospital Carlos Andrade Marin; Servicio de Oncología
City
Quito
ZIP/Postal Code
2569
Country
Ecuador
Facility Name
Hospital Solca Quito; Oncologia
City
Quito
ZIP/Postal Code
EC170124
Country
Ecuador
Facility Name
Clinique Claude Bernard; Onco Hematologie
City
Albi
ZIP/Postal Code
81030
Country
France
Facility Name
Centre Hospitalier Uni Ire; Service de Medecine D
City
Angers
ZIP/Postal Code
49033
Country
France
Facility Name
Institut Bergonie; Hematologie Oncologie
City
Bordeaux
ZIP/Postal Code
33076
Country
France
Facility Name
Polyclinique Bordeaux Nord Aquitaine; Chimiotherapie Radiotherapie
City
Bordeaux
ZIP/Postal Code
33077
Country
France
Facility Name
Centre Francois Baclesse; Comite 2
City
Caen
ZIP/Postal Code
14076
Country
France
Facility Name
Chu Estaing; Cons Hemato Medecine Interne
City
Clermont Ferrand
ZIP/Postal Code
63003
Country
France
Facility Name
Chu Site Du Bocage;Hematologie Clinique
City
Dijon
ZIP/Postal Code
21079
Country
France
Facility Name
CH Dptal Les Oudairies; Hematologie Oncologie
City
La Roche Sur Yon
ZIP/Postal Code
85925
Country
France
Facility Name
Hopital Albert Michallon; Oncologie
City
La Tronche
ZIP/Postal Code
38700
Country
France
Facility Name
Clinique Victor Hugo; Chimiotherapie
City
Le Mans
ZIP/Postal Code
72015
Country
France
Facility Name
Hopital Claude Huriez; Hematologie
City
Lille
ZIP/Postal Code
59037
Country
France
Facility Name
Hopital Uni Ire Dupuytren; Hematologie
City
Limoges
ZIP/Postal Code
87042
Country
France
Facility Name
Centre Leon Berard; Departement Oncologie Medicale
City
Lyon
ZIP/Postal Code
69373
Country
France
Facility Name
Institut J Paolii Calmettes; Onco Hematologie 1
City
Marseille
ZIP/Postal Code
13273
Country
France
Facility Name
Clinique Pont de Chaume; Oncologie Et Radiotherapie
City
Montauban
ZIP/Postal Code
82017
Country
France
Facility Name
Hopital Saint Eloi; Hematologie Oncologie Medicale
City
Montpellier
ZIP/Postal Code
34295
Country
France
Facility Name
Hopital de L'Archet; Hematologie Clinique
City
Nice
ZIP/Postal Code
06202
Country
France
Facility Name
Polyclinique Kenval ; Radiotherapie Oncologie
City
Nimes
ZIP/Postal Code
30900
Country
France
Facility Name
Institut Curie; Oncologie Medicale
City
Paris
ZIP/Postal Code
75231
Country
France
Facility Name
Hopital Saint Louis ; Service d Oncologie Medicale Fougere 6 (Pr Misset)
City
Paris
ZIP/Postal Code
75475
Country
France
Facility Name
Hopital Pitie Salpetriere; Hematologie Clinique
City
Paris
ZIP/Postal Code
75651
Country
France
Facility Name
Hopital Saint Jean; Hematologie
City
Perpignan
ZIP/Postal Code
66046
Country
France
Facility Name
Hopital De Haut Leveque; Hematologie Clinique
City
Pessac
ZIP/Postal Code
33604
Country
France
Facility Name
Ch Lyon Sud; Hemato Secteur Jules Courmont
City
Pierre Benite
ZIP/Postal Code
69495
Country
France
Facility Name
Hopital De La Miletrie; Hematologie Et Oncologie Medicale
City
Poitiers
ZIP/Postal Code
86021
Country
France
Facility Name
Ch Jacques Puel;Oncologie Medicale
City
Rodez
ZIP/Postal Code
12027
Country
France
Facility Name
ICL; Hematologie
City
Saint-Priest en Jarez
ZIP/Postal Code
42271
Country
France
Facility Name
Hopital Sud; Hematologie Clinique
City
Salouel
ZIP/Postal Code
80480
Country
France
Facility Name
Hopital Purpan; Hematologie Clinique
City
Toulouse
ZIP/Postal Code
31059
Country
France
Facility Name
Clinique Pasteur; Oncologie Medicale
City
Toulouse
ZIP/Postal Code
31076
Country
France
Facility Name
Hopital Bretonneau; Hematologie Therapie Cellulaire
City
Tours
ZIP/Postal Code
37044
Country
France
Facility Name
Hopitaux De Brabois; Hematologie Medecine Interne
City
Vandoeuvre Les Nancy
ZIP/Postal Code
54511
Country
France
Facility Name
Institut Gustave Roussy; Unite D'Hematologie
City
Villejuif
ZIP/Postal Code
94805
Country
France
Facility Name
Gesundheitszentrum St. Marien GmbH; Med. II, Hämatologie/Onkologie
City
Amberg
ZIP/Postal Code
92224
Country
Germany
Facility Name
Charité-Universitätsm. Berlin; Med. Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunolo.
City
Berlin
ZIP/Postal Code
10117
Country
Germany
Facility Name
Charité; Onkologie & Hämatologie
City
Berlin
ZIP/Postal Code
10117
Country
Germany
Facility Name
DIAKO Ev. Diakonie-Krankenhaus Bremen GmbH; Med. Klinik II; Hämatologie und internistische Onkologie
City
Bremen
ZIP/Postal Code
28239
Country
Germany
Facility Name
Carl-Thiem-Klinik Cottbus; Medizinische Klinik
City
Cottbus
ZIP/Postal Code
03048
Country
Germany
Facility Name
Klinikzentrum Mitte; Medizinische Klinik Gastroenterologie Haematologie / Onkologie
City
Dortmund
ZIP/Postal Code
44137
Country
Germany
Facility Name
St. Johannes Hospital; Abt. Innere Medizin
City
Dortmund
ZIP/Postal Code
44137
Country
Germany
Facility Name
St Antonius Hospital; Haematologie/Onkologie
City
Eschweiler
ZIP/Postal Code
52249
Country
Germany
Facility Name
Krankenhaus Nordwest Medizinische Klinik
City
Frankfurt
ZIP/Postal Code
60488
Country
Germany
Facility Name
Klinik Fulda; Abt. Itz
City
Fulda
ZIP/Postal Code
36043
Country
Germany
Facility Name
Universitätsklinikum Greifswald Klinik für Innere Medizin C und Poliklinik
City
Greifswald
ZIP/Postal Code
17475
Country
Germany
Facility Name
Georg-August-Uniklinik ; Zentrum Innere Medizin Abt. Hämatologie & Onkologie
City
Göttingen
ZIP/Postal Code
37075
Country
Germany
Facility Name
Kath.Krankenhaus Hagen gem.GmbH St.-Marien-Hospital
City
Hagen
ZIP/Postal Code
58095
Country
Germany
Facility Name
Asklepios Klinik St. Georg; Allgemeine Innere Medizin
City
Hamburg
ZIP/Postal Code
20099
Country
Germany
Facility Name
Facharztzentrum Eppendorf, Studien GbR
City
Hamburg
ZIP/Postal Code
20249
Country
Germany
Facility Name
Evang.Krankenhaus Abt. Hämatologie und Onkologie
City
Hamm
ZIP/Postal Code
59063
Country
Germany
Facility Name
St.-Marien-Hospital Klinik Knappenstraße; Klinik für Hämatologie und Onkologie
City
Hamm
ZIP/Postal Code
59071
Country
Germany
Facility Name
KRH Klinikum Siloah Medizinische Klinik III
City
Hannover
ZIP/Postal Code
30449
Country
Germany
Facility Name
St. Bernward-Krankenhaus
City
Hildesheim
ZIP/Postal Code
31134
Country
Germany
Facility Name
Universitaetsklinikum des Saarlandes; medizinische Klinik und Poliklinik; Innere Medizin I
City
Homburg/Saar
ZIP/Postal Code
66421
Country
Germany
Facility Name
Städtisches Klinikum Karlsruhe gGmbH, II. Medizinische Klinik
City
Karlsruhe
ZIP/Postal Code
76133
Country
Germany
Facility Name
St. Vincentius Kliniken Ag; Medizinische Klinik Abt. 2
City
Karlsruhe
ZIP/Postal Code
76137
Country
Germany
Facility Name
Tagesklinik Landshut; Hämatologie/Onkologie
City
Landshut
ZIP/Postal Code
84028
Country
Germany
Facility Name
Universitätsklinikum Leipzig Medizinische Klinik II Gastroenterolog. u. Hepatolog.
City
Leipzig
ZIP/Postal Code
04103
Country
Germany
Facility Name
Klinikum St.Georg gGmbH Klinik für Internistische Onkologie und Hämotologie
City
Leipzig
ZIP/Postal Code
04129
Country
Germany
Facility Name
Klinikum der Stadt Ludwigshafen; Medizinische Klinik A
City
Ludwigshafen
ZIP/Postal Code
67063
Country
Germany
Facility Name
Universitätsklinikum Schleswig-Holstein / Campus Lübeck, Med. Klinik I, Hämatologie/Onkologie
City
Lübeck
ZIP/Postal Code
23562
Country
Germany
Facility Name
Märkische Kliniken GmbH, Klinikum Lüdenscheid; Hämatologie / Onkologie
City
Lüdenscheid
ZIP/Postal Code
58515
Country
Germany
Facility Name
Otto von Guericke Uni Magdeburg Uniklinik; Hämatologie/Onkologie
City
Magdeburg
ZIP/Postal Code
39120
Country
Germany
Facility Name
Klinikum Magdeburg gemeinnützige GmbH; Klinik Haematologie und Onkologie
City
Magdeburg
ZIP/Postal Code
39130
Country
Germany
Facility Name
Klinikum Mannheim III. Medizinische Klinik
City
Mannheim
ZIP/Postal Code
68167
Country
Germany
Facility Name
Klinikum der Universitaet Muenchen; Campus Großhadern; Medizinische Klinik III und Poliklinik
City
Muenchen
ZIP/Postal Code
81377
Country
Germany
Facility Name
Westfälische Wilhelms-Universität Münster, Medizinische Klinik und Poliklinik A
City
Münster
ZIP/Postal Code
48149
Country
Germany
Facility Name
Klinikum Oldenburg gGmbH; Klinik für Onkologie und Hämatologie
City
Oldenburg
ZIP/Postal Code
26133
Country
Germany
Facility Name
Prosper-Hospital, Medizinische Klinik I
City
Recklinghausen
ZIP/Postal Code
45659
Country
Germany
Facility Name
St Marien Krankenhaus; Medizinische Klinik Iii
City
Siegen
ZIP/Postal Code
57072
Country
Germany
Facility Name
Klinikum Mutterhaus der Borromaeerinnen gGmbH; Haematologie/Onkologie
City
Trier
ZIP/Postal Code
54290
Country
Germany
Facility Name
Krankenhaus der Barmherzigen Brüder Trier; Innere Medizin I, Hämatologie / Internistische Onkologie
City
Trier
ZIP/Postal Code
54292
Country
Germany
Facility Name
Eberhard-Karls-Universität Tübingen; Medizinische Klinik I
City
Tübingen
ZIP/Postal Code
72076
Country
Germany
Facility Name
Universitätsklinikum Ulm; Medizinische Uni-Klinik III Abt. Innere Medizin III Hämatologie u. Onkolo.
City
Ulm
ZIP/Postal Code
89081
Country
Germany
Facility Name
HSK Dr.-Horst-Schmidt-Kliniken; Innere Medizin I Kardiologie; Angiologie und Intensivmedizin
City
Wiesbaden
ZIP/Postal Code
65199
Country
Germany
Facility Name
Helios Klinik Wuppertal; Medizinische Klinik I
City
Wuppertal
ZIP/Postal Code
42283
Country
Germany
Facility Name
Kliniken St. Antonius; Zentrum Für Innere Medizin, Haematologie/Onkologie
City
Wuppertal
ZIP/Postal Code
42283
Country
Germany
Facility Name
Georgios Papanikolaou Hospital; Hematology Department
City
Thessaloniki
ZIP/Postal Code
570 10
Country
Greece
Facility Name
Queen Elizabeth Hospital; Clinical Oncology
City
Hong Kong
Country
Hong Kong
Facility Name
Queen Mary Hospital; Dept of Medicine
City
Hong Kong
Country
Hong Kong
Facility Name
Fov. Onk. Egyesitett Szent Istvan es Szent Laszlo Korhaz; Dept Of Bone Marrow Transplant
City
Budapest
ZIP/Postal Code
1097
Country
Hungary
Facility Name
National Institute of Oncology, A Dept of Internal Medicine
City
Budapest
ZIP/Postal Code
1122
Country
Hungary
Facility Name
University of Debrecen Medical and Health Science Center, Institute of Internal Medicine, Hematology
City
Debrecen
ZIP/Postal Code
4032
Country
Hungary
Facility Name
A.O. Universitaria Policlinico S.Orsola-Malpighi Di Bologna
City
Bologna
State/Province
Emilia-Romagna
ZIP/Postal Code
40138
Country
Italy
Facility Name
Ospedale Regionale Di Parma; Divisione Di Oncologia Medica
City
Parma
State/Province
Emilia-Romagna
ZIP/Postal Code
43100
Country
Italy
Facility Name
Az. Osp. Arcispedale S. Maria Nuova; U.O. Di Ematologia
City
Reggio Emilia
State/Province
Emilia-Romagna
ZIP/Postal Code
42100
Country
Italy
Facility Name
Irccs Centro Di Riferimento Oncologico (CRO); Dipartimento Di Oncologia Medica
City
Aviano
State/Province
Friuli-Venezia Giulia
ZIP/Postal Code
33081
Country
Italy
Facility Name
A.O. Universitaria S. Maria Della Misericordia Di Udine; Oncologia; Clinica Ematologica
City
Udine
State/Province
Friuli-Venezia Giulia
ZIP/Postal Code
33100
Country
Italy
Facility Name
Univ. Cattolica La Sapienza; Cattedra Di Ematologia
City
Roma
State/Province
Lazio
ZIP/Postal Code
00161
Country
Italy
Facility Name
ASST DI MONZA; Ematologia
City
Monza
State/Province
Lombardia
ZIP/Postal Code
20052
Country
Italy
Facility Name
Irccs Policlinico San Matteo; Divisione Di Ematologia
City
Pavia
State/Province
Lombardia
ZIP/Postal Code
27100
Country
Italy
Facility Name
Ospedale Gen.Le Prov.Le 'C.G.Mazzoni'; Ematologia
City
Ascoli Piceno
State/Province
Marche
ZIP/Postal Code
63100
Country
Italy
Facility Name
Università Cattolica Del Sacro Cuore S.S. Giovanni Paolo Ii; Uoc Di Onco-Ematologia
City
Campobasso
State/Province
Molise
ZIP/Postal Code
86100
Country
Italy
Facility Name
Az. Osp. S. Luigi Gonzaga; Malattie Apparato Respiratorio 5 Ad Indirizzo Oncologico
City
Orbassano
State/Province
Piemonte
ZIP/Postal Code
10043
Country
Italy
Facility Name
A.O. Universitaria S. Giovanni Battista-Molinette Di Torino; Ematologia 1
City
Torino
State/Province
Piemonte
ZIP/Postal Code
10126
Country
Italy
Facility Name
Irccs Ist. Tumori Giovanni Paolo Ii; Dipartimento Oncologia Medica
City
Bari
State/Province
Puglia
ZIP/Postal Code
70124
Country
Italy
Facility Name
Ospedale Ferrarotto; Divisione Di Ematologia
City
Via S. Sofia 78
State/Province
Sicilia
ZIP/Postal Code
95123
Country
Italy
Facility Name
Ospedale Santa Chiara; Unita Operativa Di Ematologia
City
Pisa
State/Province
Toscana
ZIP/Postal Code
56100
Country
Italy
Facility Name
Samsung Medical Centre; Oncology
City
Seoul
ZIP/Postal Code
135-170
Country
Korea, Republic of
Facility Name
Asan Medical Center, Uni Ulsan Collegemedicine; Dept.Internal Medicine / Divisionhematology/Oncology
City
Seoul
ZIP/Postal Code
138-736
Country
Korea, Republic of
Facility Name
Korean Cancer Center Hospital; Oncology
City
Seoul
ZIP/Postal Code
139-709
Country
Korea, Republic of
Facility Name
Severance Hospital - Yonsei University; Medicine Dept.
City
Seoul
Country
Korea, Republic of
Facility Name
Seamen' Hospital' Dept. of haematology
City
Klaipeda
ZIP/Postal Code
92288
Country
Lithuania
Facility Name
Uni Hospital Santariskiu Clinic; Haematology
City
Vilnius
ZIP/Postal Code
08661
Country
Lithuania
Facility Name
Hospital Pulau Pinang
City
Penang
ZIP/Postal Code
10990
Country
Malaysia
Facility Name
Instituto Biomedico De Investigacion A.C.
City
Aguascalientes
ZIP/Postal Code
20127
Country
Mexico
Facility Name
Hospital Español; Hematología Sala 19
City
Mexico City
ZIP/Postal Code
11520
Country
Mexico
Facility Name
Col Instituto Tecnologico Y Estudios Superiores de Monterrey
City
Monterrey
ZIP/Postal Code
00000
Country
Mexico
Facility Name
Hospital Universitario Dr. Jose E. Gonzalez; Haematology
City
Monterrey
ZIP/Postal Code
64460
Country
Mexico
Facility Name
North Shore Hospital; Haematolgy
City
Auckland
ZIP/Postal Code
1309
Country
New Zealand
Facility Name
Uni of Auckland; Dept of Molecular Medicine & Haematology
City
Auckland
Country
New Zealand
Facility Name
Christchurch Hospital; Canterbury Health Laboratories
City
Christchurch
Country
New Zealand
Facility Name
Centro Hemato Oncologico Paitilla
City
Panama City
ZIP/Postal Code
083200752
Country
Panama
Facility Name
Hospital Nacional Almanzor Aguinaga Asenjo; Unidad De Investigacion Del Servicio De Oncologia Medica
City
Chiclayo
ZIP/Postal Code
CIX
Country
Peru
Facility Name
Hospital Nacional Edgardo Rebagliati Martins; Oncologia
City
Lima
ZIP/Postal Code
11
Country
Peru
Facility Name
Hospital Nacional Guillermo Almenara Irigoyen; Oncology
City
Lima
ZIP/Postal Code
13
Country
Peru
Facility Name
Instituto Nacional de Enfermedades Neoplasicas
City
Lima
ZIP/Postal Code
34
Country
Peru
Facility Name
Hospital Nacional LNS dela Policia Nacional del Perú. Unidad Onco; Deapartamento de Oncología
City
Lima
ZIP/Postal Code
Lima11
Country
Peru
Facility Name
Cebu Cancer Institute; Perpetual Succour Hospital
City
Cebu
ZIP/Postal Code
6000
Country
Philippines
Facility Name
National Kidney and Transplant Institute; Chemotherapy Unit
City
Diliman, Quezon City
ZIP/Postal Code
1100
Country
Philippines
Facility Name
St Luke'S Medical Centre; Oncology
City
Quezon City
ZIP/Postal Code
1114
Country
Philippines
Facility Name
Szpital Specjalistyczny Podkarpacki Ośrodek Onkologiczny
City
Brzozów
ZIP/Postal Code
36-200
Country
Poland
Facility Name
Szpital Uniwersytecki W Krakowie; Klinika Hematologii
City
Krakow
ZIP/Postal Code
31-501
Country
Poland
Facility Name
Medical University School; Dept. of Haematology
City
Lodz
ZIP/Postal Code
93-510
Country
Poland
Facility Name
Katedra i Klinika Hematoonkologii i Transplantacji Szpiku; Uniwersytetu Medycznego w Lublinie
City
Lublin
ZIP/Postal Code
20-081
Country
Poland
Facility Name
Zaklad Opieki Zdrowotnej Mswia; Oddzial Chemioterapii
City
Olsztyn
ZIP/Postal Code
10-228
Country
Poland
Facility Name
Samodzielny Publiczny Centralny Szpital Kliniczny; Haematology Dept.
City
Warszawa
ZIP/Postal Code
02-097
Country
Poland
Facility Name
Centralny Szpital Kliniczny Mswia; Klinika onkologii, hematologii i chorob wewnetrznych
City
Warszawa
ZIP/Postal Code
02-507
Country
Poland
Facility Name
Centrum Onkologii - Inst.Im. Marii Sklodowskiej-Curie; Lymphoma Dept.
City
Warszawa
ZIP/Postal Code
02-781
Country
Poland
Facility Name
HUC; Servico de Hematologia
City
Coimbra
ZIP/Postal Code
3000-075
Country
Portugal
Facility Name
IPO de Lisboa; Servico de Hematologia
City
Lisboa
ZIP/Postal Code
1099-166
Country
Portugal
Facility Name
Hospital de Sao Joao; Servico de Hematologia Clinica
City
Porto
ZIP/Postal Code
4200-319
Country
Portugal
Facility Name
Republican Clinical Oncologic Dispensary of Republic Of Tatarstan
City
Kazan
ZIP/Postal Code
420029
Country
Russian Federation
Facility Name
N.N.Blokhin Russian Cancer Research Center; Dept. of Chemotherapy & Hemoblastosis
City
Moscow
ZIP/Postal Code
115478
Country
Russian Federation
Facility Name
Haematology Research Center; Haematology
City
Moscow
ZIP/Postal Code
125167
Country
Russian Federation
Facility Name
Semashko Central Clinical Hospital Moscow; Hematology
City
Moscow
ZIP/Postal Code
129128
Country
Russian Federation
Facility Name
Research Inst. of Hematology & Blood Transfusion ; Hematology
City
St Petersburg
ZIP/Postal Code
191024
Country
Russian Federation
Facility Name
National Cancer Inst. ; Dept. of Chemotherapy
City
Bratislava
ZIP/Postal Code
833 10
Country
Slovakia
Facility Name
Hospital Mutua de Terrassa; Servicio de Hematologia
City
Terrassa
State/Province
Barcelona
ZIP/Postal Code
08221
Country
Spain
Facility Name
Hospital Universitario Marques de Valdecilla; Servicio de Hematologia
City
Santander
State/Province
Cantabria
ZIP/Postal Code
39008
Country
Spain
Facility Name
Complejo Hospitalario Universitario A Coruña (CHUAC); Servicio de Hematologia
City
La Coruna
State/Province
La Coruña
ZIP/Postal Code
15006
Country
Spain
Facility Name
Hospital Universitario de Canarias;servicio de Oncologia
City
La Laguna
State/Province
Tenerife
ZIP/Postal Code
38320
Country
Spain
Facility Name
Hospital de Basurto; Servicio de Hematologia
City
Bilbao
State/Province
Vizcaya
ZIP/Postal Code
48013
Country
Spain
Facility Name
Hospital de Galdakano
City
Galdakano
State/Province
Vizcaya
ZIP/Postal Code
48960
Country
Spain
Facility Name
Hospital de la Santa Creu i Sant Pau; Servicio de Hematologia
City
Barcelona
ZIP/Postal Code
08025
Country
Spain
Facility Name
Hospital Universitari Vall d'Hebron; Servicio de Hematologia
City
Barcelona
ZIP/Postal Code
08035
Country
Spain
Facility Name
Hospital Clínic i Provincial; Servicio de Hematología y Oncología
City
Barcelona
ZIP/Postal Code
08036
Country
Spain
Facility Name
Hospital Duran i Reynals; Servicio de Hematologia
City
Barcelona
ZIP/Postal Code
08907
Country
Spain
Facility Name
Complejo Hospitalario de Jaen- Hospital Universitario Medico Quirurgico; Servicio de Hematologia
City
Jaen
ZIP/Postal Code
23007
Country
Spain
Facility Name
Hospital Universitario Clínico San Carlos; Servicio de Hematología
City
Madrid
ZIP/Postal Code
28040
Country
Spain
Facility Name
Hospital Universitario la Paz; Servicio de Hematologia
City
Madrid
ZIP/Postal Code
28046
Country
Spain
Facility Name
Hospital Clinico Universitario Virgen de la Victoria; Servicio de Oncologia
City
Malaga
ZIP/Postal Code
29010
Country
Spain
Facility Name
Hospital Clinico Universitario de Salamanca;Servicio de Hematologia
City
Salamanca
ZIP/Postal Code
37007
Country
Spain
Facility Name
Hospital Universitario Virgen del Rocio; Servicio de Hematologia
City
Sevilla
ZIP/Postal Code
41013
Country
Spain
Facility Name
Hospital Universitario la Fe; Servicio de Medicina Intena
City
Valencia
ZIP/Postal Code
46009
Country
Spain
Facility Name
Hospital Clinico Universitario de Valencia; Servicio de Onco-hematologia
City
Valencia
ZIP/Postal Code
46010
Country
Spain
Facility Name
Hospital Universitario Miguel Servet; Servicio Hematologia
City
Zaragoza
ZIP/Postal Code
50009
Country
Spain
Facility Name
Skånes University Hospital, Skånes Department of Onclology
City
Lund
ZIP/Postal Code
22185
Country
Sweden
Facility Name
Skånes Universitetssjukhus; Kliniska Forskningsenheten Onkologimottagning medicinsk behandling
City
Malmö
ZIP/Postal Code
205 02
Country
Sweden
Facility Name
Länssjukhuset; Medicinkliniken
City
Sundsvall
ZIP/Postal Code
85186
Country
Sweden
Facility Name
Akademiska sjukhuset, Onkologkliniken
City
Uppsala
ZIP/Postal Code
75185
Country
Sweden
Facility Name
Universitätsspital Zürich; Klinik für Onkologie
City
Zürich
ZIP/Postal Code
8091
Country
Switzerland
Facility Name
Veterans General Hospital; Division of Oncology
City
Taipei
ZIP/Postal Code
00112
Country
Taiwan
Facility Name
Koo Foundation Sun Yat-Sen Cancer Center; Hemato-Oncology
City
Taipei
ZIP/Postal Code
112
Country
Taiwan
Facility Name
Chang Gung Medical Foundation-Taipei
City
Taoyuan
ZIP/Postal Code
333
Country
Taiwan
Facility Name
King Chulalongkorn Memorial Hospital; Division of Hematology, Department of Medicine
City
Bangkok
ZIP/Postal Code
10330
Country
Thailand
Facility Name
National Cancer Inst.
City
Bangkok
ZIP/Postal Code
10400
Country
Thailand
Facility Name
Rajavithi Hospital; Medicine
City
Bangkok
ZIP/Postal Code
10400
Country
Thailand
Facility Name
Siriraj Hospital; Division of Hematology, Department of Medicine
City
Bangkok
ZIP/Postal Code
10700
Country
Thailand
Facility Name
Chiang Mai Uni Hospital; Division of Hematology,Dept of Medicine,Faculty of Medicine
City
Chiang Mai
ZIP/Postal Code
50200
Country
Thailand
Facility Name
Srinagarind Hospital, Khon Kaen Uni ; Dept of Medicine
City
Khon Kaen
ZIP/Postal Code
40002
Country
Thailand
Facility Name
Birmingham Heartlands Hospital; Department of Haematology
City
Birmingham
ZIP/Postal Code
B9 5SS
Country
United Kingdom
Facility Name
Bradford Royal Infirmary; Haematology Department
City
Bradford
ZIP/Postal Code
BD9 6RJ
Country
United Kingdom
Facility Name
North Hampshire Hospital; Dept. of Haematology
City
Hampshire
ZIP/Postal Code
RG24 9NA
Country
United Kingdom
Facility Name
Princess Alexandra Hospital; Department of Haematology
City
Harlow
ZIP/Postal Code
CM20 1QX
Country
United Kingdom
Facility Name
Leicester Royal Infirmary; Dept. of Medical Oncology
City
Leicester
ZIP/Postal Code
LE1 5WW
Country
United Kingdom
Facility Name
Royal Liverpool Uni Hospital; Haematology
City
Liverpool
ZIP/Postal Code
L7 8XP
Country
United Kingdom
Facility Name
St. George'S Hospital; Haematology
City
London
ZIP/Postal Code
SW17 0QT
Country
United Kingdom
Facility Name
Hillingdon Hospital
City
Middx
ZIP/Postal Code
UB8 3NN
Country
United Kingdom
Facility Name
Churchill Hospital; Oxford Cancer and Haematology Centre
City
Oxford
ZIP/Postal Code
OX3 7LJ
Country
United Kingdom
Facility Name
Royal Hallamshire Hospital; Haematology Dept
City
Sheffield
ZIP/Postal Code
S10 2JF
Country
United Kingdom
Facility Name
Weston Park Hospital; Cancer Clinical Trials Centre
City
Sheffield
ZIP/Postal Code
S10 2SJ
Country
United Kingdom
Facility Name
The Royal Wolverhampton Hospitals NHS Trust; Department of Haematology
City
Wolverhampton
ZIP/Postal Code
WV10 0QP
Country
United Kingdom

12. IPD Sharing Statement

Citations:
PubMed Identifier
30770362
Citation
McCord R, Bolen CR, Koeppen H, Kadel EE 3rd, Oestergaard MZ, Nielsen T, Sehn LH, Venstrom JM. PD-L1 and tumor-associated macrophages in de novo DLBCL. Blood Adv. 2019 Feb 26;3(4):531-540. doi: 10.1182/bloodadvances.2018020602.
Results Reference
derived
PubMed Identifier
24895339
Citation
Seymour JF, Pfreundschuh M, Trneny M, Sehn LH, Catalano J, Csinady E, Moore N, Coiffier B; MAIN Study Investigators. R-CHOP with or without bevacizumab in patients with previously untreated diffuse large B-cell lymphoma: final MAIN study outcomes. Haematologica. 2014 Aug;99(8):1343-9. doi: 10.3324/haematol.2013.100818. Epub 2014 Jun 3.
Results Reference
derived

Learn more about this trial

A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma

We'll reach out to this number within 24 hrs